Related Experiment Video
Updated: Sep 24, 2025

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
Published on: July 25, 2025
CD56dim NK Cell is an Important Factor in T Cell Depletion of cART-Treated AIDS Patients
Feng Qian1,2,3, Song Hu4, Yueping Zhu2,3
1Department of Infectious Diseases, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
Insights
Poor immune reconstitution in HIV-1 patients on combination antiretroviral therapy (cART) is linked to reduced red blood cells and lymphocytes, elevated PD-1 expression, and over-activated NK cells. These factors offer insights for improving immune recovery strategies.
Area of Science:
- Immunology
- Virology
- Hematology
Background:
- Combination antiretroviral therapy (cART) is standard for human immunodeficiency virus 1 (HIV-1) management.
- T-cell depletion remains a concern in some cART-treated HIV-1 patients, impacting immune reconstitution.
- Understanding factors contributing to poor immune reconstitution is crucial for optimizing treatment outcomes.
Purpose of the Study:
- To investigate factors associated with T-cell depletion in HIV-1-positive patients undergoing cART.
- To identify potential indicators of poor immune reconstitution.
Main Methods:
- Flow cytometry was used to analyze CD4+, CD8+ T cell subsets, and CD56dim NK cells in 29 HIV-1-positive patients.
- Cytokine concentrations were measured using enzyme-linked immunosorbent assay.
- Viral load was quantified using the Roche Cobas Ampliprep/Cobas TaqMan HIV-1 test.
Main Results:
- Patients with inadequate immune reconstitution (INR) showed reduced red blood cells (RBCs) and lymphocytes (LCs) compared to immune-reconstituted (IR) patients, with a positive correlation between RBCs and LCs.
- INR patients exhibited lower T-cell cytokine production but markedly elevated programmed death-1 (PD-1) expression on CD4+ and CD8+ T cells.
- Increased proportion and killing ability of CD56dim NK cells were observed in INR patients, correlating with T-lymphocyte apoptosis.
Conclusions:
- Poor immune reconstitution in HIV-1 patients may stem from bone marrow suppression, high PD-1 expression on CD4+ T cells, and over-activated T and NK cells.
- NK cell activity and RBC counts may serve as valuable auxiliary indicators for assessing immune reconstitution.
- These findings can guide strategies to enhance immune reconstitution in HIV-1-positive individuals.
Purpose:
To investigate factors involved in T-cell depletion in combination antiretroviral therapy (cART)-treated human immunodeficiency virus 1 (HIV-1)-positive patients.
Patients And Methods:
29 HIV-1-positive patients were enrolled. The CD4+, CD8+ T cell subsets and CD56dim NK cells were detected by flow cytometry. The concentrations of cytokines were measured by enzyme-linked immunosorbent assay. Extraction, amplification, and viral load quantification of specimens were performed using the Roche Cobas Ampliprep/Cobas TaqMan HIV-1 test.
Results:
Compared with IR group, the total number of red blood cells (RBCs) and lymphocytes (LCs) in INR group was significantly reduced, and there was a significant positive correlation between the number of RBCs and that of LCs. The overall production rates of T cells-related cytokines were lower in INR group. However, the cell-surface expression of programmed death-1 (PD-1) on CD4+ T and CD8+ T cells were markedly elevated in INR group. Moreover, it was found that the proportion and the killing ability of CD56dim NK cells significantly increased in INR patients, and significantly correlated with apoptosis of T lymphocytes.
Conclusion:
A poor immune reconstitution in HIV-positive patients might result from multiple factors, including bone marrow suppression, high PD-1 expression on the surface of CD4+ T cells, and over-activation of T and NK cells. Besides, the activity of NK cells and RBCs count might be important auxiliary indicators for immune reconstitution and provided a reliable guidance for developing strategies to improve immune reconstitution.
More Related Videos
12:07Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
Published on: March 14, 2011
08:12Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014